| Session | ||
6.H: In-silico Toxicology
| ||
| Presentations | ||
9:00am - 9:15am
6.H: 1 Prediction of higher airway particle deposition in children compared with adults: A modelling study Auckland Bioengineering Institute, New Zealand 9:15am - 9:30am
6.H: 2 Towards a virtual embryo: Computational modeling of neural tube closure defects 1Utrecht University, The Netherlands; 2IRAS, Utrecht University, The Netherlands; 3Biocomplexity Institute, Indiana University, Bloomington, United States; 4Department of Physics, NC State University, Raleigh, North Carolina, United States; 5U.S. EPA/ORD, Research Triangle Park, North Carolina, United States 9:30am - 9:45am
6.H: 3 Development of a multiscale data-driven lung model to understand the health effects of vaping 1Auckland Bioengineering Institute, University of Auckland, New Zealand; 2Department of Anatomy & Medical Imaging, University of Auckland, New Zealand 9:45am - 10:00am
6.H: 4 Building disease ontology maps: In silico tools for applications in toxicology 1Biomechanics Research Unit, GIGA In Silico Medicine, University of Liège, Liège, Belgium; 2Department of In Vitro Toxicology and Dermato-cosmetology, Vrije Universiteit Brussel, Brussels, Belgium; 3IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany; 4Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; 5Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; 6Innovative Testing in Life Sciences & Chemistry, University of Applied Sciences Utrecht, The Netherlands; 7ToxTrack, Baltimore, MD, USA; 8Center for Alternatives to Animal Testing (CAAT) - Europe, University of Konstanz, Germany; CAAT, Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins University, Doerenkamp-Zbinden Chair for Evidence-based Toxicology, Baltimore, MD, USA; 9Departamento de Bioquímica y Biología Molecular, Universidad de Valencia, Valencia, Spain; Experimental Hepatology and Liver Transplant Unit, Health Research Institute La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; 10Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; 11Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands; 12Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Biomechanics Section, Department of Mechanical Engineering, KU Leuven, Leuven, Belgium 10:00am - 10:15am
6.H: 5 Modelling toxicity after prostate cancer radiotherapy using genetically guided pixel-wise analysis 1Fondazione IRCCS - Istituto Nazionale dei Tumori, Italy; 2Politecnico di Milano, Italy; 3German Cancer Research Center (DKFZ), Germany; 4Icahn School of Medicine at Mount Sinai, US; 5Université de Montpellier, France; 6University of Manchester, UK; 7Maastricht University Medical Centre, The Netherland; 8University Hospitals Leuven, Belgium; 9University Medical Centre Mannheim, Germany; 10University of Leicester, UK; 11Fundaciòn Pùblica Galega Medicina Xenòmica, Spain; 12Ghent University Hospital, Belgium; 13Medical College of Wisconsin, US; 14University of Cambridge, UK; 15Vall d'Hebron Institute of Oncology, Spain 10:15am - 10:30am
6.H: 6 Virtual Cornea: A computational approach for predicting corneal injury and recovery from chemical exposures 1Department of Intelligent Systems Engineering and Biocomplexity Institute, Indiana University, Bloomington, IN;; 2Center for Computational Toxicology and Exposure, Office of Research and Development, United States Environmental Protection Agency, Research Triangle Park, NC;; 3Procter & Gamble, Technical Centre, Reading, United Kingdom | ||